This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schneider, M. P Articles by Schmieder, R. E Search for Related Content PubMed PubMed Citation Articles by Schneider, M. P Articles by Schmieder, R. E Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ATENOLOL Medline Plus Health Information High Blood Pressure Social Bookmarking                         What's this?

Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial

Department of Medicine IV/Nephrology, University of Erlangen-Nürnberg, Germany

Christian Delles

Department of Medicine IV/Nephrology, University of Erlangen-Nürnberg, Germany

Arnfried U Klingbeil

Department of Medicine IV/Nephrology, University of Erlangen-Nürnberg, Germany

Malte Ludwig

Department of Medicine, University of Bonn, Germany

Rainer E Kolloch

Department of Medicine, Gilead Medical Center, Germany

Michael Krekler

Bristol-Myers Squibb, Munich, Germany

Klaus O Stumpe

Department of Medicine, University of Bonn, Germany

Roland E Schmieder

Department of Medicine IV/Nephrology, University of Erlangen-Nürnberg, Germany, roland.schmieder @rzmail.uni-erlangen.de

Objective. Angiotensin-converting enzyme (ACE) inhibitors have been shown to lower central augmentation index (cAI), an index of arterial wave reflection, more than β-blockers. We tested whether this is also true for long-term treatment with an angiotensin receptor blocker (ARB).

Methods. One-hundred and fifty-six subjects with essential hypertension were randomised to treatment with either irbesartan or atenolol. cAI and central blood pressure (BP) were determined by pulse wave analysis from the radial and the carotid artery after six and after 18 months treatment.

Results. Peripheral and central systolic and diastolic BP were reduced to a similar extent A in the two groups. cAI was reduced with irbesartan, but increased with atenolol (derived from the carotid artery: -6±10 vs. -4±12% after six months, p<0.001; —4±12 vs. +1±11% after 18 months; p=0.011). Furthermore, central to peripheral pulse pressure (PP) amplification was unaffected by treatment with irbesartan, but decreased with atenolol.

Conclusions. Although treatment with irbesartan and atenolol similarly decreased peripheral and central BP, only treatment with irbesartan had beneficial effects on arterial wave reflection and preserved PP amplification. These haemodynamic effects may at least partly explain the reported differential effects of ARB versus β-blocker treatment on cardiovascular mortality in patients with essential hypertension.

Key Words: aorta • blood pressure • blood vessels • renin-angiotensin system • therapeutics

References

• Morgan T., Lauri J., Bertram D., Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004;17:118-23.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ting CT, Chen CH, Chang MS, Yin FC Short- and long-term effects of antihypertensive drugs on arterial reflections, compliance, and impedance. Hypertension 1995;26:524-30.[Abstract/Free Full Text]
• Chen CH, Nevo E., Fetics B. et al. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure. Validation of generalised transfer function. Circulation 1997;95:1827-36.[Abstract/Free Full Text]
• Pauca AL, O'Rourke MF, Kon ND Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001;38A:932-7.[Abstract/Free Full Text]
• London GM, Blacher J., Pannier B., Guerin AP, Marchais SJ, Safar ME Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001;38:434-8.[Abstract/Free Full Text]
• Chirinos JA, Zambrano JP, Chakko S. et al. Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. Hypertension 2005;45:980-5.[Abstract/Free Full Text]
• Millasseau SC, Patel SJ, Redwood SR, Ritter JM, Chowienczyk PJ Pressure wave reflection assessed from the peripheral pulse: is a transfer function necessary? Hypertension 2003;41:1016-20.[Abstract/Free Full Text]
• London GM, Asmar RG, O'Rourke MF, Safar ME Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. JACC 2004;43:92-9.[Abstract/Free Full Text]
• Williams B., Lacy PS, Thom SM et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113:1213-25.[Abstract/Free Full Text]
• Safar ME, Blacher J., Pannier B. et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002;39:735-8.[Abstract/Free Full Text]
• Bradley HA, Wiysonge CS, Volmink JA, Mayosi BM, Opie LH How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis. J Hypertens 2006;24:2131-41.[Web of Science][Medline] [Order article via Infotrieve]
• Carlberg B., Samuelsson O., Lindholm LH Atenolol in hypertension: is it a wise choice? Lancet 2004;364:1684-9. 13. Khan N., McAlister FA Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. CMAJ 2006;174:1737-42.[Abstract/Free Full Text]
• Chen CH, Ting CT, Nussbacher A. et al. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension 1996;27:168-75.[Abstract/Free Full Text]
• Kelly RP, Hayward CS, Ganis J., Daley J., Avolio A., O'Rourke M. Non-invasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry. J Vasc Med Biol 1989;1:142-9.
• Klingbeil AU, John S., Schneider MP, Jacobi J., Weidinger G., Schmieder RE AT1-receptor blockade improves augmentation index: a double-blind, randomised, controlled study. J Hypertens 2002;20:2423-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dahlof B., Devereux RB, Kjeldsen SE et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002;359:995-1003.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Dhakam Z., McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens 2006;19:214-19.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Mahmud A., Feely J. Effect of angiotensin II receptor blockade on arterial stiffness: beyond blood pressure reduction. Am J Hypertens 2002;15:1092-95. 20. Kelly RP, Millasseau SC, Ritter JM, Chowienczyk PJ[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 2001;37:1429-33.[Abstract/Free Full Text]
• Klingbeil AU, John S., Schneider MP, Jacobi J., Handrock R., Schmieder RE Effect of AT1-receptor blockade on endothelial function in essential hypertension. Am J Hypertens 2003;16:123-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schiffrin EL, Park JB, Intengan HD, Touyz RM Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000;101:1653-9.[Abstract/Free Full Text]
• Schindler C., Bramlage P., Kirch W., Ferrario CM Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy. Vascu Health Risk Manage 2007;3:125-37.
• Schindler C., Brosnihan KB, Ferrario CM et al. Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomised double-blind crossover trial in healthy subjects. J Clin Pharmacol 2007;47:112-20.[Abstract/Free Full Text]
• Wilkinson IB, MacCallum H., Flint L., Cockcroft JR, Newby DE, Webb DJ The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000;525:263-270.[Abstract/Free Full Text]
• Deary AJ, Schumann AL, Murfet H., Haydock S., Foo RS, Brown MJ Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension. Clin Sci (Lond) 2002;103:493-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Luchner A., Burnett JC, Jr., Jougasaki M., Hense HW, Riegger GA, Schunkert H. Augmentation of the cardiac natriuretic peptides by beta-receptor antagonism: evidence from a population-based study. JACC 1998;32:1839-44.[Abstract/Free Full Text]
• McEniery CM, Schmitt M., Qasem A. et al. Nebivolol increases arterial distensibility in vivo. Hypertension 2004;44:305-10.[Abstract/Free Full Text]
• Lund-Johansen P. Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension. Br J Clin Pharmacol 1976;3:445-51.[Web of Science][Medline] [Order article via Infotrieve]

Journal of Renin-Angiotensin-Aldosterone System, Vol. 9, No. 1, 49-56 (2008)
DOI: 10.3317/jraas.2008.003


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schneider, M. P Articles by Schmieder, R. E Search for Related Content PubMed PubMed Citation Articles by Schneider, M. P Articles by Schmieder, R. E Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ATENOLOL Medline Plus Health Information High Blood Pressure Social Bookmarking                         What's this?